Jump to content
  • Sign Up

Cannabis helps after strokes


Recommended Posts

Potential Drug Target for Stroke Identified

 

New research by University of Otago scientists suggests some mechanisms in the brain targeted by cannabis could become drugs targets to counter brain cell damage after a stroke.

 

Researchers from the Medical School's Department of Pharmacology and Toxicology have been the first in the world to show the cannabinoid CB2 receptor appears in the rat brain following a stroke. Their findings were published recently in the journal Neuroscience Letters.

 

Dr John Ashton says the CB2 receptor is a protein produced as part of the body's immune response system.

 

"This response is triggered by stroke and causes the inflammation that leads to damage in the area of the brain around where the stroke has occurred.

 

"If the inflammation can be stopped or reduced then it offers the hope of reducing the extent of the damage caused by stroke - and CB2 offers a potential target for such a drug."

 

Dr Ashton says cannabis targets both the CB2 and the related CB1 receptors.

 

"THC, the major active ingredient of cannabis, acts mainly on CB1 but it also affects CB2. While THC is known to have some positive effects in terms of pain management its use is severely limited because of the way it triggers the psychoactive CB1 receptors in the brain," he says.

 

"The aim would be to develop a drug that targets the CB2 receptor without affecting CB1."

 

Dr Ashton says the relationship between cannabis and cannabinoid drugs has similarities to the relationship between heroin and codeine.

 

"Heroin and codeine share common targets, but by designing codeine in such a way that it eliminated the psychoactive side-effects seen with heroin, a therapeutically useful drug was developed. There is the potential to do the same with cannabinoids."

 

Drugs targeting CB2 could also have potential therapeutic use in other conditions involving inflammatory damage to the brain, such as Huntington's Disease and Alzheimer's Disease. There may also be scope to use them in pain management.

 

"CB2 cells are also found in the spinal cord. They regulate pain signals making them a potential target for new pain killing drugs."

 

Dr Ashton has a collaborator in Colorado who is currently conducting a study on that.

 

For more information contact:

 

Dr John Ashton

Department of Pharmacology and Toxicology

Tel 03 479 3040

Email john.ashton@stonebow.otago.ac.nz

 

Author: University of Otago

Date: Wednesday 11 April 2007

Source: University of Otago

Copyright: University of Otago

 

:wacko:

Link to comment
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Restore formatting

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

×
×
  • Create New...

Important Information

By using the community in any way you agree to our Terms of Use and We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.